In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Qualitative and Quantitative Analysis Report 2028

In-vitro Toxicology Assays Industry For Cannabis And Nicotine Testing Overview

The in-vitro toxicology assays market size for cannabis and nicotine testing was valued at USD 1,236.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028.

Rising usage of products based on cannabis and nicotine and the introduction of technologically advanced products are factors driving the in-vitro toxicology assay market for cannabis and nicotine testing. In addition, the rise in an adolescent population, which is more prone to use nicotine and cannabis-related products, will aid in market growth. Furthermore, the number of countries legalizing the use of medical cannabis is expected to increase in the coming years resulting in increasing usage of medical cannabis across the globe. The potential for significant tax revenues from cannabis is another factor that has resulted in an increasing number of counties legalizing its medical use.

Gather more insights about the market drivers, restrains and growth of the Global In-vitro Toxicology Assays For Cannabis And Nicotine Testing Market

Canada in-vitro toxicology assays market size for cannabis and nicotine testing, by application, 2018 - 2028 (USD Million)

In the past few years, awareness regarding medical applications of cannabis (marijuana), such as appetite enhancement, pain management, and reducing eye pressure, is increasing. Owing to this factor, the number of countries legalizing the use of medical cannabis in various parts of this world is continuously increasing. For instance, most U.S. states have legally approved the use and commercialization of medical cannabis and an increasing number of countries are legalizing the plant for recreational use.

The increasing incidence of nicotine consumption-associated diseases has triggered the launch of various policies and initiatives by governments and global organizations to increase awareness among people. For instance, the CDC has initiated a project for reducing the consumption of sodium and tobacco to prevent COPD and cardiac disorders in China.

In recent years, the use of cannabis products has expanded, leading to an increasing number of specialized cannabis testing laboratories. This intensified the market completion. For instance, with rigorous legislative requirements and high sample throughput, Laboratory Information Management Systems (LIMS) serve as a promising tool for a testing laboratory.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Laboratory Information Management System Market – The global laboratory information management system market size was valued at USD 1.85 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2022 to 2030.
  • Medical Marijuana Market – The global medical marijuana market size was valued at USD 11.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 21.06% from 2022 to 2030.

Market Share Insights

  • July 2021: IONTOX announced a collaboration with cbdMD, Inc. to identify novel cannabinoids for therapeutic use. The company is expected to perform the required toxicological studies with cbdMD Therapeutics.

Key Companies profiled:

Some prominent players in the global in-vitro toxicology assays market for cannabis and nicotine testing include

  • Stemina Biomarker Discovery, Inc.
  • Broughton Nicotine Services
  • Labstat International, Inc.
  • IONTOX
  • TOXIKON
  • Integrated Laboratory Systems
  • Enthalpy Analytical
  • PBR Laboratories, Inc.

Order a free sample PDF of the in-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Intelligence Study, published by Grand View Research.

Comments are closed